Lab Compliance Deep Dive: LCD/NCD Gaps and How to Protect Your Revenue

The claim went out clean. The test was ordered. The patient qualified. And then the denial arrived anyway. If that sequence sounds familiar, your lab is likely losing revenue to a coverage gap that your current billing system cannot see. Local Coverage Determinations and National Coverage Determinations govern whether Medicare will pay for a test, under what circumstances, and with what documentation attached. When those rules are not built into your billing workflow, the errors do not announce themselves. They hide inside an aging AR report and a denial pile that keeps growing.

LCD and NCD compliance is one of the most consequential and least-discussed revenue risks in laboratory billing. It is not a clerical issue. It is a structural one. And in today's enforcement environment, it carries both financial and legal exposure that no lab can afford to let run unchecked. The 2026 laboratory billing and compliance landscape has made these gaps more visible to payers and auditors than at any point in the past decade.

This is a practical guide to what LCD and NCD gaps actually are, how they drain revenue, what regulators are looking for, and how a properly built laboratory billing operation prevents them from becoming a recurring problem.

What LCDs and NCDs Are, and Why They Create Billing Risk

A National Coverage Determination is a nationwide Medicare policy that defines whether a specific item or service is covered, covered with conditions, or not covered at all. CMS issues NCDs directly and they apply uniformly across all Medicare Administrative Contractors. A Local Coverage Determination serves a similar function but is issued by individual MACs for their own jurisdictions and can vary significantly from one region to the next.

The College of American Pathologists has consistently highlighted that laboratory claims rank among the most scrutinized categories in Medicare billing, in part because test volumes are high and coverage rules are genuinely complex. A single molecular diagnostic panel may be covered under one MAC's LCD but require specific diagnosis codes or medical necessity documentation to qualify in another jurisdiction. Miss either distinction and the claim denies. Miss it consistently at volume and the problem becomes a compliance exposure on top of a revenue one.

According to CMS, Medicare Administrative Contractors maintain hundreds of active LCDs covering laboratory and pathology services, and those policies update on an ongoing basis. A billing operation that does not track those changes in real time is always working from an incomplete picture of what will and will not pay. In 2026, payer enforcement of LCD requirements has become more automated and more aggressive, meaning errors that once resulted in a simple denial are now triggering post-payment review.

The Two Ways LCD/NCD Gaps Hurt Labs at the Same Time

Most compliance discussions focus on regulatory risk. Most revenue cycle discussions focus on denial rates. LCD and NCD gaps do both simultaneously, and that combination is what makes them particularly dangerous for labs that discover the problem late.

A lab billing a test outside LCD coverage requirements is not just generating a denial. It may be generating a false claim exposure under federal audit standards if the pattern is systematic and the lab cannot demonstrate that coverage rules were applied correctly before the claim was submitted. The Dark Report has documented that DOJ enforcement activity targeting clinical laboratory billing has accelerated significantly over recent years, with particular attention to labs submitting high volumes of claims for tests that lack adequate medical necessity documentation or fall outside applicable LCD criteria.

Labs often discover this exposure too late. A routine audit surfaces a pattern. A payer data analysis flags a volume outlier. By that point, the question is no longer whether the lab has a compliance gap. The question is how large it is and how long it has been running. The relationship between LCD gaps and broader revenue cycle health is one reason why the conversation about in-house versus outsourced lab billing matters so much right now. The expertise required to manage coverage determinations correctly at scale is significant, and not every internal team has it.

Where LCD/NCD Gaps Typically Form in Lab Billing Operations

LCD and NCD gaps do not usually result from intentional billing errors. They result from systems and processes that were not built to handle the complexity of coverage determinations at laboratory claim volumes. Understanding where these gaps form is the first step toward closing them before a denial pattern becomes an audit finding.

Most lab billing operations that struggle with LCD/NCD compliance share a recognizable set of structural weaknesses. These are not isolated mistakes. They are patterns that repeat across thousands of claims when the underlying system lacks specialty-specific coverage logic. The features that separate strong lab billing software from generic RCM platforms show up most clearly here, because a general billing tool has no mechanism to validate coverage at the test level. Walk through each of these areas to assess where your operation is most exposed:

• No LCD mapping at the test level. The billing system does not link specific CPT codes to the applicable LCD in your MAC jurisdiction. Claims go out without coverage validation, so covered and non-covered tests move through the same workflow with no distinction applied at the point of submission.
• Missing or incomplete diagnosis code requirements. Many LCDs require specific ICD-10 codes to establish medical necessity. When ordering providers submit incomplete or imprecise diagnosis information, the lab bills without the required supporting code and the claim denies on a requirement that should have been caught before submission.
• Advance Beneficiary Notice gaps. When a test falls outside LCD coverage, labs must issue an ABN to the patient before the service to preserve the right to bill the patient if Medicare denies. A system that does not flag non-covered tests before the order processes cannot trigger the ABN workflow in time to protect the revenue.
• Stale coverage logic. LCDs are updated by MACs on a rolling basis throughout the year. A billing operation that does not actively track policy changes may apply coverage criteria from a previous version to current claims, creating systematic errors across every test affected by that update.
• No jurisdiction-specific differentiation. Labs operating across multiple states may be subject to different LCDs from different MACs for the same test code. A billing system with a single national rule set cannot correctly manage coverage determinations for a multi-state or regional testing operation.
• Reflex and panel billing errors. When a reflex test or expanded panel triggers based on an initial result, the additional codes must be validated against coverage requirements independently. Systems that do not apply LCD logic to reflex billing generate coverage violations on tests the lab may not have intended to process outside covered indications.

The Connection Between LCD Gaps and the Tests Labs Bill Without Coverage

Not every test your lab performs has an active LCD governing its coverage. New molecular diagnostics, emerging genetic tests, and certain specialty panels may fall into a gray zone where no formal coverage determination exists yet. Billing those tests profitably and compliantly requires a different strategy than billing covered tests, but it starts with the same discipline: knowing exactly which of your CPT codes have LCD coverage, which do not, and what the documentation and patient notification requirements are for each category.

The approach to billing laboratory tests without LCDs is a distinct operational challenge from managing LCD compliance on covered tests. Both require specialty-specific billing infrastructure. But conflating the two, treating non-covered tests the same way as covered tests with LCD requirements, is one of the most common sources of both revenue loss and compliance exposure in laboratory billing today.

The AACC notes that laboratory professionals who engage proactively with coverage policy changes are consistently better positioned to prevent billing errors than those who respond reactively to denials and audits. That proactive posture requires a billing system built to surface coverage status at the moment the order is processed, not after the claim has already been submitted and denied.

What the OIG and DOJ Are Looking for in Lab Audits

The Office of Inspector General has identified laboratory billing as a persistent focus area in its annual Work Plan. The patterns regulators flag most consistently involve labs submitting high volumes of claims where the diagnosis coding does not support the clinical indication required by the applicable LCD, where ABNs were not issued before non-covered services were performed, or where claim patterns suggest systematic application of CPT codes without underlying coverage validation.

CMS and its MAC contractors have the ability to conduct post-payment audits that look back across your claims history. A coverage gap that has been running in your billing operation for 18 months does not read as 18 months of honest mistakes when a government auditor reviews the pattern. It reads as a systemic process failure. Under the False Claims Act, potential liability is calculated as a multiple of the overpayment amount, not the overpayment itself.

The labs that come through audits cleanly are the ones that can demonstrate they had a coverage validation process in place before the claim left the building, that ABN documentation is consistent and complete across their patient records, and that their billing team actively monitored LCD changes and updated workflows accordingly. That level of documentation does not happen by accident. It happens because the billing infrastructure was designed to produce it. The regulatory and reimbursement pressure labs face in 2026 makes this infrastructure investment more urgent, not less.

What a Protected Lab Billing Operation Looks Like

Protection against LCD/NCD exposure is not a quarterly compliance checklist activity. It is a daily operational discipline built into the billing workflow itself. The difference between a lab that comes through a Medicare audit intact and one that does not often comes down to whether their billing system was built specifically for laboratory coverage complexity or adapted from a general billing platform that was never designed to handle it.

General RCM tools have no concept of what an LCD is, cannot validate ABN documentation at the line level, and have no mechanism for tracking MAC-specific policy changes across jurisdictions. That is not a configuration problem. It is a structural one. You cannot patch general billing logic into laboratory-grade coverage compliance with a workaround or a manual process layered on top.

ADS has supported laboratory billing operations with specialty-specific rules engines built around LCD and NCD logic since 1977. The ADSRCM platform processes nearly 50 million EDI transactions annually and maintains a nearly 99% first-pass clean claim rate because coverage validation happens before the claim leaves the system, not after the denial arrives. Labs working with ADS get U.S.-based support that answers in under two minutes, a team with deep laboratory billing expertise, and a billing infrastructure that tracks LCD changes actively rather than reacting to denials after the fact.

That distinction matters at scale. A lab processing thousands of claims per month cannot afford to discover LCD gaps through denial patterns. By the time the pattern is visible in a report, the financial and compliance exposure is already real. For labs evaluating whether their current model can sustain that discipline, the comparison between in-house billing teams and AI-supported RCM is worth a direct look at where the coverage validation gaps are most likely to form.

Ready to see what AI built into 49 years of specialty-specific laboratory billing looks like in practice?

Request a Live Demonstration and see how ADSRCM applies LCD and NCD validation logic to your actual test menu and payer mix. A real person answers in under two minutes at 1-800-899-4237 ext. 2264.

Sources: CMS Medicare Coverage Database (cms.gov/medicare/coverage) | College of American Pathologists (cap.org) | AACC (aacc.org) | The Dark Report (darkreport.com) | OIG Work Plan (oig.hhs.gov)